{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:20:22Z","timestamp":1790799622489,"version":"4.1.0"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100010518","name":"College of Human Medicine, Michigan State University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010518","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001734","name":"K\u00f8benhavns Universitet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001734","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.tox.2019.152247","type":"journal-article","created":{"date-parts":[[2019,7,19]],"date-time":"2019-07-19T11:28:46Z","timestamp":1563535726000},"page":"152247","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"special_numbering":"C","title":["The classic azole antifungal drugs are highly potent endocrine disruptors in vitro inhibiting steroidogenic CYP enzymes at concentrations lower than therapeutic Cmax"],"prefix":"10.1016","volume":"425","author":[{"given":"Cecilie Hurup","family":"Munkboel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias Bangsgaard","family":"Rasmussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla","family":"Elgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja-Luna Kingo","family":"Olesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas Christopher","family":"Kretschmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bjarne","family":"Styrishave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.tox.2019.152247_bib0005","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1007\/s11908-015-0462-0","article-title":"Vulvovaginal candidiasis in pregnancy","volume":"17","author":"Aguin","year":"2015","journal-title":"Curr. Infect. Dis. Rep."},{"issue":"2","key":"10.1016\/j.tox.2019.152247_bib0010","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1517\/13543780903381411","article-title":"Ketoconazole enantiomer for the treatment of diabetes mellitus","volume":"19","author":"Arakaki","year":"2010","journal-title":"Expert Opin. Investig. Drugs"},{"issue":"4","key":"10.1016\/j.tox.2019.152247_bib0015","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/0022-4731(89)90384-1","article-title":"Inhibition of human adrenal steroidogenic enzymes in vitro by imidazole drugs including ketoconazole","volume":"32","author":"Ayub","year":"1989","journal-title":"J. Steroid Biochem."},{"issue":"5","key":"10.1016\/j.tox.2019.152247_bib0020","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1007\/s11356-013-1474-7","article-title":"Effect of in vivo chronic exposure to clotrimazole on zebrafish testis function","volume":"20","author":"Baudiffier","year":"2013","journal-title":"Environ. Sci. Pollut. Res. Int."},{"key":"10.1016\/j.tox.2019.152247_bib0025","first-page":"29468","article-title":"Promising tools in prostate cancer research \u2014 selective non-steroidal cytochrome P450 17A1 inhibitors","volume":"6","author":"Bonomo","year":"2016","journal-title":"Nat. Sci. Rep."},{"issue":"1","key":"10.1016\/j.tox.2019.152247_bib0030","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1128\/AAC.21.1.151","article-title":"Disposition of ketoconazole, an oral antifungal, in humans","volume":"21","author":"Brass","year":"1982","journal-title":"Antimicrob. Agents Chemother."},{"issue":"191","key":"10.1016\/j.tox.2019.152247_bib0035","article-title":"Antifungal drugs and the risk of selected birth defects","volume":"198","author":"Carter","year":"2008","journal-title":"Am J Obstet Gynocol."},{"issue":"1","key":"10.1016\/j.tox.2019.152247_bib0040","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1517\/14728214.10.1.21","article-title":"Emerging azole antifungals","volume":"10","author":"Chen","year":"2005","journal-title":"Expert Opin. Emerg. Drugs"},{"key":"10.1016\/j.tox.2019.152247_bib0045","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1056\/NEJM199401273300407","article-title":"Oral azole drugs as systemic antifungal therapy","volume":"330","author":"Como","year":"1994","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.tox.2019.152247_bib0050","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/S0002-9378(98)80028-8","article-title":"Epidemiology and outcomes associated with moderate to heavy Candida colonization during pregnancy. Vaginal Infections and Prematurity Study Group","volume":"178","author":"Cotch","year":"1998","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.tox.2019.152247_bib0055","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1046\/j.1365-3016.1999.00157.x","article-title":"A lower rate of preterm birth after clotrimazole therapy during pregnancy","volume":"13","author":"Czeizel","year":"1999","journal-title":"Paediatr. Perinat. Epidemiol."},{"key":"10.1016\/j.tox.2019.152247_bib0060","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1741-4520.2004.00007.x","article-title":"Population-based case-control teratologic study of topical miconazole","volume":"44","author":"Czeizel","year":"2004","journal-title":"Congenit. Anom. (Kyoto)"},{"issue":"6","key":"10.1016\/j.tox.2019.152247_bib0065","doi-asserted-by":"crossref","first-page":"R263","DOI":"10.1530\/EJE-14-1014","article-title":"Therapy of endocrine disease: steroidogenesis enzyme inhibitors in Cushing\u2019s syndrome","volume":"172","author":"Daniel","year":"2015","journal-title":"Eur. J. Endocrinol."},{"issue":"12","key":"10.1016\/j.tox.2019.152247_bib0070","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1056\/NEJMcp053720","article-title":"Clinical practice. Acute vulvovaginitis","volume":"355","author":"Eckert","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.tox.2019.152247_bib0075","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/0022-4731(88)90291-9","article-title":"Effects of two oral antimycotics, ketoconazole and fluconazole, upon steroidogenesis in rat adrenal cells in vitro","volume":"31","author":"Eckhoff","year":"1988","journal-title":"J. Steroid Biochem."},{"issue":"8","key":"10.1016\/j.tox.2019.152247_bib0080","first-page":"636","article-title":"Effect of fluconazole on the fertility of male rabbits","volume":"52","author":"El-Medany","year":"2002","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.tox.2019.152247_bib0085","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.bmc.2017.11.030","article-title":"Design, synthesis and evaluation against Mycobacterium tuberculosis of azole piperazine derivatives as dicyclotyrosine (cYY) mimics","volume":"26","author":"El-Wahab","year":"2018","journal-title":"Bioorg. Med. Chem."},{"issue":"2","key":"10.1016\/j.tox.2019.152247_bib0090","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1365-2125.1984.tb02334.x","article-title":"Systemic absorption of ketoconazole from vaginal pessaries","volume":"17","author":"Ene","year":"1984","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.tox.2019.152247_bib0095","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4137\/CMRH.S14036","article-title":"Selective inhibition of steroidogenic enzymes by ketoconazole in rat ovary cells","volume":"8","author":"Gal","year":"2014","journal-title":"Clin. Med. Insights Reprod. Health"},{"issue":"5","key":"10.1016\/j.tox.2019.152247_bib0100","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S1369-5274(98)80087-8","article-title":"Antifungals: mechanism of action and resistance, established and novel drugs","volume":"1","author":"Georgopapadakou","year":"1998","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.tox.2019.152247_bib0105","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.toxlet.2010.07.005","article-title":"Are azole fungicides a teratogenic risk for human cenceptus?","volume":"198","author":"Giavini","year":"2010","journal-title":"Tox Lett."},{"key":"10.1016\/j.tox.2019.152247_bib0110","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.reprotox.2015.10.005","article-title":"Simvastatin decreases steroid production in the H295R cell line and decreases steroids and FSH in female rats","volume":"58","author":"Guldvang","year":"2015","journal-title":"Reprod. Toxicol."},{"issue":"2","key":"10.1016\/j.tox.2019.152247_bib0115","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1517\/14740338.2015.983071","article-title":"Drug safety assessment of oral formulations of ketoconazole. Expert opinion on drug safety","volume":"14","author":"Gupta","year":"2015","journal-title":"Expert Opin. Drug Saf."},{"issue":"5","key":"10.1016\/j.tox.2019.152247_bib0120","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1128\/AAC.32.5.646","article-title":"Fluconazole and testosterone: in vivo and in vitro studies","volume":"32","author":"Hanger","year":"1988","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.tox.2019.152247_bib0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tiv.2017.02.001","article-title":"The six most widely used selective serotonin reuptake inhibitors decrease androgens and increase estrogens in the H295R cell line","volume":"41","author":"Hansen","year":"2017","journal-title":"Toxicol. In Vitro"},{"issue":"3","key":"10.1016\/j.tox.2019.152247_bib0130","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/j.1939-4640.1992.tb00298.x","article-title":"The effect of ketoconazole on endocrine and reproductive parameters in male mice and rats","volume":"13","author":"Heckman","year":"1992","journal-title":"J. Androl."},{"issue":"2","key":"10.1016\/j.tox.2019.152247_bib0135","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1254\/jjp.79.213","article-title":"YM116, 2-(1H-imidazol-4-ylmethyl)-9H-carbazole, decreases adrenal androgen synthesis by inhibiting C17-20 lyase activity in NCI-H295 human adrenocortical carcinoma cells","volume":"79","author":"Ideyama","year":"1999","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/j.tox.2019.152247_bib0140","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.tiv.2017.10.029","article-title":"Steroidogenic disruptive effects of the serotonin-noradrenaline reuptake inhibitors duloxetine, venlafaxine and tramadol in the H295R cell assay and in a recombinant CYP17 assay","volume":"47","author":"Islin","year":"2018","journal-title":"Toxicol. In Vitro"},{"issue":"12","key":"10.1016\/j.tox.2019.152247_bib0145","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1007\/s00228-010-0906-2","article-title":"Systemic uptake of miconazole during vaginal suppository use and effect on CYP1A2 and CYP3A4 associated enzyme activities in women","volume":"66","author":"Kjaerstad","year":"2010","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"4","key":"10.1016\/j.tox.2019.152247_bib0150","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.reprotox.2010.07.009","article-title":"Endocrine disrupting effects in vitro of conazole antifungals used as pesticides and pharmaceuticals","volume":"30","author":"Kjaerstad","year":"2010","journal-title":"Reprod. Toxicol."},{"issue":"3","key":"10.1016\/j.tox.2019.152247_bib0155","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1081\/ERC-120015045","article-title":"Assessing pregnancy risks of azole antifungals using a high throughput aromatase inhibition assay","volume":"28","author":"Kragie","year":"2002","journal-title":"Endocr. Res."},{"key":"10.1016\/j.tox.2019.152247_bib0160","doi-asserted-by":"crossref","first-page":"E715","DOI":"10.1073\/pnas.1715035115","article-title":"Ibuprofen alters human testicular physiology to produce a state of compensated hypogonadism","volume":"115","author":"Kristensen","year":"2018","journal-title":"Proc. Nat. Acad. Sci. U. S. A."},{"issue":"12","key":"10.1016\/j.tox.2019.152247_bib0165","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1016\/0006-2952(92)90682-9","article-title":"Ketoconazole inhibition of the bifunctional cytochrome P450c17 does not affect androgen formation from the endogenous lyase substrate","volume":"44","author":"K\u00fchn-Velten","year":"1992","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.tox.2019.152247_bib0170","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0022-3565(25)22688-X","article-title":"Differential effects of the imidazole derivatives etomidate, ketoconazole and miconazole and of metyrapone on the secretion of cortisol and its precursors by human adrenocortical cells","volume":"240","author":"Lamberts","year":"1987","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tox.2019.152247_bib0175","series-title":"DrugBank [Online]","author":"Law","year":"2018"},{"issue":"5","key":"10.1016\/j.tox.2019.152247_bib0180","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1172\/JCI110903","article-title":"Ketoconazole blocks adrenal steroidogenesis by inhibiting cytochrome P450-dependent enzymes","volume":"71","author":"Loose","year":"1983","journal-title":"J. Clin. Invest."},{"issue":"7","key":"10.1016\/j.tox.2019.152247_bib0185","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1021\/jo102459w","article-title":"Asymmetric chemoenzymatic synthesis of miconazole and econazole enantiomers. The importance of chirality in their biological evaluation","volume":"76","author":"Mangas-Sanchez","year":"2011","journal-title":"J. Org. Chem."},{"issue":"1\u20133","key":"10.1016\/j.tox.2019.152247_bib0190","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0039-128X(83)90070-3","article-title":"Imidazole antimycotics: selective inhibitors of steroid aromatization and progesterone hydroxylation","volume":"50","author":"Mason","year":"1987","journal-title":"Steroids"},{"issue":"7","key":"10.1016\/j.tox.2019.152247_bib0195","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/0006-2952(85)90613-6","article-title":"Imidazole antimycotics: inhibitors of steroid aromatase","volume":"34","author":"Mason","year":"1985","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.tox.2019.152247_bib0200","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1128\/AAC.43.1.148","article-title":"Penetration of oral fluconazole into gynecological tissues","volume":"43","author":"Mikamo","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"issue":"9","key":"10.1016\/j.tox.2019.152247_bib0205","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1056\/NEJMoa1301066","article-title":"Use of oral fluconazole during pregnancy and the risk of birth defects","volume":"369","author":"Molgaard-Nielsen","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.tox.2019.152247_bib0210","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1001\/jama.2015.17844","article-title":"Association between use of oral fluconazole during pregnancy and risk of spontaneous abortion and stillbirth","volume":"315","author":"Molgaard-Nielsen","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.tox.2019.152247_bib0215","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1093\/biolre\/ioy098","article-title":"The antiepileptic drug Lamotrigine inhibits the CYP17A1 lyase reaction in vitro","volume":"99","author":"Munkboel","year":"2018","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.tox.2019.152247_bib0220","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1093\/toxsci\/kfy059","article-title":"Sertraline suppresses testis and adrenal steroid production and steroidogenic gene expression while increasing LH in plasma of male rats resulting in compensatory hypogonadism","volume":"163","author":"Munkboel","year":"2018","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tox.2019.152247_bib0225","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1007\/s00204-018-2187-y","article-title":"Atorvastatin decreases steroid production in H295R cells and in major endocrine tissues of male rats","volume":"92","author":"Munkboel","year":"2018","journal-title":"Arch. Toxicol. Suppl."},{"issue":"2","key":"10.1016\/j.tox.2019.152247_bib0230","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.tiv.2011.12.008","article-title":"H295R cells as a model for steroidogenic disruption: a broader perspective using simultaneous chemical analysis of 7 key steroid hormones","volume":"26","author":"Nielsen","year":"2012","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.tox.2019.152247_bib0235","series-title":"Toxnet - Clotrimazole 8600 Rockville Pike, Bethesda, MD 20894","author":"NIH","year":"1986"},{"issue":"1","key":"10.1016\/j.tox.2019.152247_bib0240","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1093\/jac\/dkn157","article-title":"Maternal use of fluconazole and risk of congenital malformations: a Danish population-based cohort study","volume":"62","author":"Norgaard","year":"2008","journal-title":"J. Antimicrob. Chemother."},{"issue":"2","key":"10.1016\/j.tox.2019.152247_bib0245","first-page":"60","article-title":"Progesterone supplementation and the prevention of preterm birth","volume":"4","author":"Norwitz","year":"2011","journal-title":"Rev. Obstet. Gynecol."},{"key":"10.1016\/j.tox.2019.152247_bib0250","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1056\/NEJM198709243171307","article-title":"Drug therapy: the use of ketoconazole as an inhibitor of steroid production","volume":"317","author":"Oates","year":"1987","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.tox.2019.152247_bib0255","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S0966-842X(03)00117-3","article-title":"Antifungal agents: mechanisms of action","volume":"11","author":"Odds","year":"2003","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.tox.2019.152247_bib0260","series-title":"Test No. 456: H295R Steroidogenesis Assay","author":"OECD","year":"2011"},{"issue":"1\u20133","key":"10.1016\/j.tox.2019.152247_bib0265","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.tox.2010.05.013","article-title":"Mixture effects of imidazole fungicides on cortisol and aldosterone secretion in human adrenocortical H295R cells","volume":"275","author":"Ohlsson","year":"2010","journal-title":"Toxicology"},{"issue":"2","key":"10.1016\/j.tox.2019.152247_bib0270","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1086\/380796","article-title":"Guidelines for treatment of candidiasis","volume":"38","author":"Pappas","year":"2004","journal-title":"Clin. Infect. Dis."},{"issue":"1","key":"10.1016\/j.tox.2019.152247_bib0275","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/jac\/dku355","article-title":"Antifungal drugs during pregnancy: an updated review","volume":"70","author":"Pilmis","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"issue":"8","key":"10.1016\/j.tox.2019.152247_bib0280","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1001\/archinte.1985.00360080103015","article-title":"Ketoconazole-induced increase in estradiol-testosterone ratio. Probable explanation for gynecomastia","volume":"145","author":"Pont","year":"1985","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.tox.2019.152247_bib0285","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1471-2393-11-18","article-title":"Treatment of asymptomatic vaginal candidiasis in pregnancy to prevent preterm birth: an open-label pilot randomized controlled trial","volume":"11","author":"Roberts","year":"2011","journal-title":"BMC Pregnancy Childbirth"},{"issue":"5","key":"10.1016\/j.tox.2019.152247_bib0290","first-page":"751","article-title":"Pregnancy outcomes after first-trimester vaginitis drug therapy","volume":"69","author":"Rosa","year":"1987","journal-title":"Obstet. Gynecol."},{"issue":"15","key":"10.1016\/j.tox.2019.152247_bib0295","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1021\/jm00093a015","article-title":"Stereoisomers of ketoconazole: preparation and biological activity","volume":"35","author":"Rotstein","year":"1992","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.tox.2019.152247_bib0300","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/toxsci\/kfl051","article-title":"The steroid hormone biosynthesis pathway as a target for endocrine-disrupting chemicals","volume":"94","author":"Sanderson","year":"2006","journal-title":"Toxicol. Sci."},{"issue":"1","key":"10.1016\/j.tox.2019.152247_bib0305","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1128\/CMR.12.1.40","article-title":"Current and emerging azole antifungal agents","volume":"12","author":"Sheehan","year":"1999","journal-title":"Clin. Microbiol. Rev."},{"issue":"5","key":"10.1016\/j.tox.2019.152247_bib0310","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1210\/endo-116-5-1920","article-title":"In vitro inhibition of testosterone biosynthesis by ketoconazole","volume":"116","author":"Sikka","year":"1985","journal-title":"Endocrinology"},{"issue":"9577","key":"10.1016\/j.tox.2019.152247_bib0315","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/S0140-6736(07)60917-9","article-title":"Vulvovaginal candidosis","volume":"369","author":"Sobel","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.tox.2019.152247_bib0320","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.tiv.2016.03.007","article-title":"Enantioselective endocrine disrupting effects of omeprazole studied in the H295R cell assay and by molecular modeling","volume":"34","author":"S\u00f8rensen","year":"2016","journal-title":"Toxicol. In Vitro"},{"issue":"2","key":"10.1016\/j.tox.2019.152247_bib0325","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1365-2605.2007.00838.x","article-title":"Endocrine-disrupting properties in vivo of widely used azole fungicides","volume":"31","author":"Taxvig","year":"2008","journal-title":"Int. J. Androl."},{"issue":"1405","key":"10.1016\/j.tox.2019.152247_bib0330","first-page":"655","article-title":"Patient and doctor preferences in the treatment of vaginal candidosis","volume":"229","author":"Tooley","year":"1985","journal-title":"Practitioner"},{"issue":"1\u20133","key":"10.1016\/j.tox.2019.152247_bib0335","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.tox.2005.10.020","article-title":"Inhibition of human CYP19 by azoles used as antifungal agents and aromatase inhibitors, using a new LC\u2013MS\/MS method for the analysis of estradiol product formation","volume":"219","author":"Tr\u00f6sken","year":"2006","journal-title":"Toxicology"},{"issue":"3","key":"10.1016\/j.tox.2019.152247_bib0340","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1530\/JOE-12-0310","article-title":"Fluconazole inhibits human adrenocortical steroidogenesis in vitro","volume":"215","author":"van der Pas","year":"2012","journal-title":"J. Endocrinol."},{"issue":"1","key":"10.1016\/j.tox.2019.152247_bib0345","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1365-2605.2005.00604.x","article-title":"Prochloraz: an imidazole fungicide with multiple mechanisms of action","volume":"29","author":"Vinggaard","year":"2006","journal-title":"Int. J. Androl."},{"issue":"4-5","key":"10.1016\/j.tox.2019.152247_bib0350","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0960-0760(00)00170-9","article-title":"Econazole and miconazole inhibit steroidogenesis and disrupt steroidogenic acute regulatory (StAR) protein expression post-transcriptionally","volume":"75","author":"Walsh","year":"2000","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.tox.2019.152247_bib0355","doi-asserted-by":"crossref","first-page":"4883","DOI":"10.1007\/s00216-016-9575-z","article-title":"Two simple cleanup methods combined with LC-MS\/MS for quantification of steroid hormones in in vivo and in vitro assays","volume":"408","author":"Weisser","year":"2016","journal-title":"Anal. Bioanal. Chem."},{"issue":"7-8","key":"10.1016\/j.tox.2019.152247_bib0360","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1439-0507.1997.tb00230.x","article-title":"Fluconazole: comparison of pharmacokinetics, therapy and in vitro susceptibility","volume":"40","author":"Wildfeuer","year":"1997","journal-title":"Mycoses"},{"issue":"1\u20132","key":"10.1016\/j.tox.2019.152247_bib0365","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1177\/074823379901500109","volume":"15","author":"Wolf","year":"1999","journal-title":"Toxicol. Ind. Health"},{"issue":"3\u20134","key":"10.1016\/j.tox.2019.152247_bib0370","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0960-0760(96)00189-6","article-title":"Calmidazolium and other imidazole compounds affect steroidogenesis in Y1 cells: lack of involvement of the peripheral-type benzodiazepine receptor","volume":"60","author":"Zisterer","year":"1997","journal-title":"J. Steroid Biochem. Mol. Biol."}],"container-title":["Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X19302033?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X19302033?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T23:42:21Z","timestamp":1759534941000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300483X19302033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":74,"alternative-id":["S0300483X19302033"],"URL":"https:\/\/doi.org\/10.1016\/j.tox.2019.152247","relation":{},"ISSN":["0300-483X"],"issn-type":[{"value":"0300-483X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The classic azole antifungal drugs are highly potent endocrine disruptors in vitro inhibiting steroidogenic CYP enzymes at concentrations lower than therapeutic Cmax","name":"articletitle","label":"Article Title"},{"value":"Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tox.2019.152247","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"152247"}}